Journal of Nuclear Medicine · 2008 · 94 citations · 29 references
MedicineNuclear MedicinePharmacologyDrug DeliveryMolecular ImagingTheranosticsAntibody CharacterizationCardiovascular Molecular ImagingLigand BindingReceptor ImagingTargeted Imaging AgentsTherapeutic Monoclonal AntibodiesAntibody-based Imaging AgentsAtherosclerosis Molecular MechanismsAtherosclerotic Plaque ImagingAtherosclerotic ProgressionLipoprotein Receptor TargetingPlaque InstabilityReceptor-targeted Imaging AgentsTargeted Contrast Agents
UNLABELLED: Lectinlike oxidized low-density lipoprotein (LDL) receptor 1 (LOX-1), a cell surface receptor for oxidized LDL, has been implicated in vascular cell dysfunction related to plaque instability, which could be a potential target for an atherosclerosis imaging tracer. In this study, we designed and prepared (99m)Tc-labeled anti-LOX-1 monoclonal IgG and investigated its usefulness as an atherosclerosis imaging agent. METHODS: Anti-LOX-1 monoclonal IgG and control mouse IgG2a were labeled with (99m)Tc after derivatization with 6-hydrazinonicotinic acid to yield (99m)Tc-LOX-1-mAb and (99m)Tc-IgG2a, respectively. Myocardial infarction-prone Watanabe heritable hyperlipidemic (WHHLMI) rabbits (atherosclerosis model) and control rabbits were injected intravenously with these probes, and in vivo planar imaging was performed. At 24 h after the injection, the aortas were removed, and radioactivity was measured. Autoradiography and histologic studies were performed with serial aortic sections. RESULTS: The level of (99m)Tc-LOX-1-mAb accumulation was 2.0-fold higher than the level of (99m)Tc-IgG2a accumulation in WHHLMI rabbit aortas, and the level of (99m)Tc-LOX-1-mAb accumulation in WHHLMI rabbit aortas was 10.0-fold higher than the level of (99m)Tc-LOX-1-mAb accumulation in control rabbit aortas. In vivo imaging clearly visualized the atherosclerotic aortas of WHHLMI rabbits. Autoradiography and histologic studies revealed that regional (99m)Tc-IgG2a accumulation was independent of the histologic grade of the lesions; however, regional (99m)Tc-LOX-1-mAb accumulation was significantly correlated with LOX-1 expression density and the vulnerability index. The highest level of (99m)Tc-LOX-1-mAb accumulation, expressed as {radioactivity in region of interest (Bq/mm(2))/[injected radioactivity (Bq)/animal body weight (g)]} x 10(2), was found in atheromatous lesions (3.8 +/- 1.1 [mean +/- SD]), followed in decreasing order by fibroatheromatous lesions (2.0 +/- 1.0), collagen-rich lesions (1.6 +/- 0.8), and neointimal lesions (1.4 +/- 0.7). CONCLUSION: The level of (99m)Tc-LOX-1-mAb accumulation in grade IV atheroma was higher than that in neointimal lesions or other, more stable lesions. Nuclear imaging of LOX-1 expression with (99m)Tc-LOX-1-mAb may be a useful means for predicting atheroma at high risk for rupture.
29
An endothelial receptor for oxidized low-density lipoprotein
Tatsuya Sawamura, Noriaki Kume, Takuma Aoyama et al. · Nature · 1997 · 1.4K citations
(18)F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study.
Mikako Ogawa, Seigo Ishino, Takahiro Mukai et al. · PubMed · 2004 · 331 citations
Jessica M. Mann, Michael J. Davies · Circulation · 1996 · 277 citations
Medicine, Cardiology, Cariology +6